CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"


- -------------------------------------------------------------------------------
                     ***CONFIDENTIAL TREATMENT REQUESTED***

      Note: Portions hereof have been omitted and filed separately with the
    Securities and Exchange Commission pursuant to a request for confidential
       treatment in accordance with Rule 24b-2 of the Securities Exchange
                            Act of 1934, as amended.
- -------------------------------------------------------------------------------


                            OPTION PURCHASE AGREEMENT

              OPTION PURCHASE  AGREEMENT (this "Agreement") made as of this 25th
day of January, 2010 between Malibu Capital Partners,  LLC, a California limited
liability  company  ("Buyer"),  and the signatory on the  execution  page hereof
("Seller").

              WHEREAS,  Overture  Acquisition  Corporation  (the  "Company"),  a
Cayman Islands corporation,  was organized for the purpose of acquiring, through
a merger,  capital stock exchange,  asset  acquisition or other similar business
combination, an operating business ("Business Combination"); and

              WHEREAS,  the Company  consummated an initial  public  offering in
January, 2008 in connection with which it raised gross proceeds of approximately
$150  million,  a  significant  portion of which was  placed in a trust  account
pending the  consummation  of a Business  Combination on or prior to January 30,
2010; and

              WHEREAS,   pursuant  to  certain   provisions   in  the  Company's
Certificate of Incorporation, as amended (the "Certificate of Incorporation"), a
holder of Common Stock issued in the Company's  initial public  offering may, if
it votes against the Business  Combination,  demand that the Company redeem such
Common Stock into cash ("Redemption Rights"); and

              WHEREAS,  the Business  Combination will not be consummated if the
holders  of  more  than  30% of the  Common  Stock  vote  against  the  Business
Combination and request Redemption Rights; and

              WHEREAS,  Buyer has requested  Seller,  and Seller has agreed,  to
enter into this  Agreement with respect to the number of shares of common stock,
par value $.0001 per share (the "Common Stock"), of the Company set forth on the
signature page hereof that Seller beneficially owns (the "Shares"); and

              WHEREAS,  Buyer has agreed to  purchase  from  Seller an option to
purchase  Seller's Common Stock at any time prior to the Termination (as defined
hereinafter) of this Agreement; and

              NOW,   THEREFORE,   in   consideration  of  the  mutual  covenants
hereinafter set forth and other good and valuable consideration, the sufficiency
of which is hereby acknowledged, the parties hereby agree as follows:


                                       -1-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

              1. OPTION. Seller hereby sells to Buyer and Buyer hereby purchases
from Seller,  concurrently  with the execution of this Agreement,  at a price of
*** per Share  (the  "Option  Price"),  an option  (the  "Purchase  Option")  to
purchase all (but not less than all) of the Shares from Seller at any time prior
to the  Termination of this  Agreement.  On execution of this  Agreement,  Buyer
shall pay to the order of Seller,  by wire  transfer  of  immediately  available
funds pursuant to the instructions set forth on SCHEDULE 1 hereto, the aggregate
Option Price.  Seller shall have  confirmed none of the Shares are being lent by
Seller, an affiliate of Seller (as such term is defined in Section 501(b) of the
Securities  Act of 1934,  as  amended) or  Seller's  broker,  to any third party
immediately prior to the execution of this Agreement.

              2.  PURCHASE.  If the  Buyer  exercises  the  Purchase  Option  in
accordance with Section 4 then at the Closing (as defined  hereinafter),  Seller
shall sell to Buyer and Buyer shall purchase from Seller,  the Shares at a price
per share (the  "Purchase  Price") equal to that certain pro rata portion of the
Company's trust account (the "Trust Amount") due its public  stockholders as set
forth in the Company's  final  definitive  proxy  statement  filed with the U.S.
Securities and Exchange  Commission  (the "SEC") in connection with the Business
Combination.

              3.  AGREEMENT TO VOTE AND REDEEM PRIOR TO EXERCISE OF THE PURCHASE
OPTION.

                  (a) VOTE AGAINST;  REDEMPTION. In further consideration of the
Option  Price and unless  withdrawn  and  revoked  pursuant to the terms of this
Agreement,  Seller hereby  agrees that within 1 business day after  execution of
this Agreement,  Seller will send an electronic and written  instruction through
its prime broker holding the Shares requesting the prime broker to: (i) exercise
its Redemption  Rights,  (ii) vote the Shares against the Business  Combination,
and  (iii)  vote  the  Shares  against  any  amendment  to  the  Certificate  of
Incorporation,  each in the manner set forth in the Company's  respective  proxy
statement(s) filed with the SEC, as applicable and in a timely manner; PROVIDED,
FURTHER,  that in all applicable cases,  Seller shall take such other actions in
connection therewith as may be reasonably requested by Buyer.

                  (b) PRIOR  VOTES.  If Seller has already  voted in  connection
with  any  such  Business   Combination  or  amendment  to  the  Certificate  of
Incorporation,   Seller  shall  either  (i)  send  an  electronic   and  written
instruction  through its prime broker  holding the Shares  requesting  the prime
broker  to  withdraw  and  revoke  Seller's  vote  in  favor  of  such  Business
Combination or amendment to the Certificate of Incorporation with respect to the
Shares or (ii) continue to vote the Shares,  against any Business Combination or
amendment to the Certificate of Incorporation;  PROVIDED,  FURTHER,  that in all
applicable cases, Seller shall exercise, or continue to exercise, its Redemption
Rights in accordance with the proxy  statement(s) and take such other actions in
connection therewith as may be reasonably requested by Buyer.

                  (c) APPOINTMENT OF PROXY.

                      (i) Subject to the limitations of Section 3(c)(ii), Seller
hereby   appoints   Kenneth  J.  Abdalla  as  its  true  and  lawful  proxy  and
attorney-in-fact,  with full power of substitution, to vote all of the Shares in
accordance  with the terms of this Agreement in a manner  consistent with Clause
5. The proxy and power of attorney  granted herein shall be deemed to be coupled
with an interest, shall be irrevocable, and shall survive the death, disability,


                                      -2-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

incompetency,  bankruptcy,  insolvency or  dissolution  of Seller.  Furthermore,
Seller will,  from time to time as  reasonably  requested by Buyer,  execute and
deliver such further  instruments,  ancillary  agreements or other  documents or
take such other  actions as may be  necessary  or  advisable  to give effect to,
confirm,  evidence  or  effectuate  the  purposes  of the proxy  granted by this
Section 3(c).  Upon the termination of this Agreement in accordance with Section
10, this Section 3(c) shall be of further force and effect.

                      (ii) This Section 3(c) shall become effective only if: (i)
Seller fails to vote the Shares in accordance with this  Agreement,  and/or (ii)
Buyer  notifies  Seller  of its  intent  to  exercise  the  Purchase  Option  in
accordance  with Section 4 and payment of the Aggregate  Purchase Price has been
made to the Escrow Agent (as defined in Section 5).

                  (d) EVIDENCE OF VOTE. Seller shall provide further evidence of
both (i) its vote against any such  Business  Combination  or  amendments to the
Certificate of Incorporation, and (ii) its exercise of Redemption Rights, within
one (1) business day of any reasonable request by Buyer for such evidence.

              4. EXERCISE OF PURCHASE OPTION.  Buyer shall exercise the Purchase
Option by delivering to Seller written notice, by electronic mail,  facsimile or
otherwise,  at the  address set forth in Section 20, such that it is received by
Seller (i) at least two  business  days prior to the Meeting or any  stockholder
vote taken by written  consent  or (ii) at least one  business  day prior to the
date set by Seller's prime broker as the date it must receive votes with respect
to the Meeting or any  stockholder  vote taken by written  consent (the later of
(i) or (ii), the "Minimum Exercise Time"),  containing (A) an acknowledgement of
Buyer's  intent to exercise the Purchase  Option and (B) whether  Seller  should
vote the Shares in favor of, against or abstain from voting upon,  each proposal
to be presented at the Meeting or upon any such action by written  consent.  The
exercisability of the Purchase Option shall terminate in accordance with Section
10 hereof.

              5.  AGREEMENT TO VOTE UPON EXERCISE OF THE PURCHASE  OPTION.  Upon
the  exercise of the  Purchase  Option and receipt by the  mutually  agreed upon
escrow agent (the "Escrow Agent") of: (i) the Aggregate  Purchase Price and (ii)
a letter in  substantially  the form of EXHIBIT B hereto:  Seller  shall send an
electronic and written  instruction  through its prime broker holding the Shares
requesting  the prime  broker  to: (1)  withdraw  and  revoke  its  exercise  of
Redemption  Rights and (2) vote in favor of, or abstain  from voting  upon,  the
Business  Combination  and the other  proposals set forth in the Proxy Statement
and/or any amendment to the  Certificate  of  Incorporation  and take such other
actions in connection  therewith as may be reasonably  requested by Buyer. Until
such time the Shares have  settled in the  account  specified  by Buyer,  Seller
shall promptly execute all necessary  documents and take all actions as, in each
case, are reasonably  requested by Buyer in furtherance of such required  action
and  revocation,  with respect to the  proposals to be submitted  (i) by written
consent of the  stockholders  of  Company,  or (ii) at the  special  (or annual)
meeting,  or  adjournment  thereof,  each as called  for by the  Company  or the
consenting  stockholders  to vote upon (A) the Business  Combination  or (B) any
amendment to the Certificate of  Incorporation  (the  "Meeting").  If, (i) Buyer
exercises the Purchase  Option prior to the  expiration of the Minimum  Exercise
Time and the Escrow Agent has confirmed receipt of the Aggregate  Purchase Price
as aforesaid  but Seller does not revoke its exercise of  redemption  rights and
vote in  favour  of (or  abstain  from  voting)  upon the  Business


                                      -3-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

Combination  pursuant to this Section 5 as a result of circumstances  beyond the
reasonable control of Seller then Buyer's sole remedy shall be the return of the
Option Price and the Aggregate  Purchase  Price  received by the Seller from the
Escrow Agent or Buyer (if any) for such subject  Shares  within one (1) business
day of the  Meeting  and Seller  shall not be obliged  to deliver  such  subject
Shares to Buyer  pursuant  to Section 6,  PROVIDED  THAT if the Shares have been
transferred to the Buyer or the Escrow Agent,  the Buyer shall procure that they
are promptly (and in any event within one (1) business day)  transferred back to
the Seller or (ii) if Buyer  exercises the Purchase  Option after the expiration
of the Minimum Exercise Time, then Seller shall use reasonable efforts to comply
with  this  Section  5;  PROVIDED,  HOWEVER,  Seller  shall  have  no  liability
whatsoever  in  connection  therewith and should Seller be unable to comply with
this Section 5, Seller shall not be obliged to deliver any non-complying  Shares
to Buyer pursuant to Section 6.

              6. CLOSING MATTERS.

                  (a)  CLOSING.  If Buyer  exercises  the Purchase  Option,  the
closing  of  the  purchase  and  sale  of  the  Shares  ("Closing")  will  occur
simultaneously with the delivery of the Shares pursuant to Section 6(b).

                  (b) CLOSING PROCEDURES.  As soon as reasonably practicable and
in any event,  within one (1)  business  day after the  exercise of the Purchase
Option and the Escrow Agent's  confirmation of receipt of the Aggregate Purchase
Price and a letter  substantially in the form of EXHIBIT B, Seller shall deliver
the Shares to Buyer  electronically  to an account  specified by Buyer. Upon the
settlement of the Shares,  the Escrow Agent shall pay to the order of Seller the
aggregate  Purchase Price by wire transfer of immediately  available funds to an
account  specified  by  Seller  in  accordance  with  EXHIBIT  B. It  shall be a
condition  to the  obligation  of Buyer on the one hand and  Seller on the other
hand, to consummate the transfer of the Shares  contemplated  hereunder that the
other  party's  representations  and  warranties  are true and correct as of the
Closing  with the same  effect as though  made on such  date,  unless  waived in
writing by the party to whom such representations and warranties are made.

              7.  REPRESENTATIONS  AND  WARRANTIES OF THE SELLER.  Seller hereby
represents and warrants to Buyer on the date hereof and on the Closing that:

                  (a) SOPHISTICATED SELLER. Seller is sophisticated in financial
matters and is able to evaluate the risks and benefits  attendant to the sale of
Shares to Buyer.

                  (b) INDEPENDENT INVESTIGATION.  Seller, in making the decision
to sell  the  Shares  to  Buyer,  has  not  relied  upon  any  oral  or  written
representations  or assurances  from Buyer or any of its officers,  directors or
employees or any other representatives or agents of Buyer. Seller has had access
to all of the  filings  made  by the  Company  with  the  SEC,  pursuant  to the
Securities  Exchange  Act of 1934,  as  amended  (the  "Exchange  Act")  and the
Securities  Act of 1933, as amended (the  "Securities  Act") in each case to the
extent available publicly via the SEC's Electronic Data Gathering,  Analysis and
Retrieval system.


                                      -4-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

                  (c)  AUTHORITY.  This  Agreement has been validly  authorized,
executed and delivered by Seller and, assuming the due authorization,  execution
and delivery thereof by Buyer, is a valid and binding  agreement  enforceable in
accordance  with its terms,  subject to the general  principles of equity and to
bankruptcy  or  other  laws  affecting  the  enforcement  of  creditors'  rights
generally.  The execution,  delivery and performance of this Agreement by Seller
does not and will not conflict with,  violate or cause a breach of, constitute a
default  under,  or result in a  violation  of (i) any  agreement,  contract  or
instrument to which Seller is a party which would prevent Seller from performing
its obligations  hereunder or (ii) any law, statute, rule or regulation to which
Seller is subject.

                  (d) NO LEGAL ADVICE FROM BUYER.  Seller  acknowledges  that it
has  had  the  opportunity  to  review  this  Agreement  and  the   transactions
contemplated  by this  Agreement  with Seller's own legal counsel and investment
and tax advisors.  Seller is not relying on any statements or representations of
Buyer or any of its  representatives  or agents  for  legal,  tax or  investment
advice with respect to this Agreement or the  transactions  contemplated  by the
Agreement.

                  (e)  OWNERSHIP  OF SHARES;  NO PROXY.  Seller is the legal and
beneficial owner of the Shares, has held the Shares for at least sixty (60) days
and will  transfer  to Buyer at the  Closing  good and  marketable  title to the
Shares free and clear of any liens, claims, security interests, options, charges
or any other encumbrance whatsoever. Seller beneficially owned all of the Shares
as of the date of this  Agreement and has the sole right to exercise  Redemption
Rights and vote the  Shares,  whether at the  Meeting or upon  action by written
consent,  with  respect  to  all of the  Shares.  Except  as  provided  by  this
Agreement,  Seller has not,  directly  or  indirectly,  granted  any  proxies or
entered into any voting trust or other agreement or arrangement  with respect to
the voting,  regardless  of whether such vote would occur at the Meeting or upon
action by written consent, of any of the Shares.

                  (f) CASH ACCOUNT.  If the Shares are not currently  held in an
account which  prohibits  rehypothecation  by the Seller's prime broker,  Seller
will transfer the Shares into such an account as soon as  practicable  following
the  execution  of this  Agreement;  PROVIDED,  HOWEVER,  in no event shall such
transfer  occur  more  than two (2)  business  days from the  execution  of this
Agreement.

                  (g)  NON-TRANSFER  OF SHARES;  NUMBER OF SHARES.  Except for a
transfer of the Shares pursuant to Section 7(g)(i) - (iii), the Shares which are
subject to the  Purchase  Option  shall not be  transferred,  sold,  assigned or
borrowed in any manner,  whether by merger,  consolidation  or  otherwise by the
operation of law, following the execution of this Agreement. Seller may transfer
the Shares under the following  circumstances:  (i) in  accordance  with Section
7(f),  (ii) to the Buyer or its assigns in  connection  with the exercise of the
Purchase Option or (iii) to the Company (via its transfer agent or otherwise) in
connection with Seller's perfection of its demand for Redemption Rights.

                  (h) SELLER TAXES.  Seller understands that Seller (and not the
Buyer) shall be responsible  for any and all tax  liabilities of Seller that may
arise as a result of the transactions contemplated by this Agreement.


                                      -5-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

              8.   REPRESENTATIONS   AND  WARRANTIES  OF  BUYER.   Buyer  hereby
represents to the Seller that:

                  (a) SOPHISTICATED  BUYER.  Buyer is sophisticated in financial
matters and is able to evaluate the risks and benefits attendant to the purchase
of Shares from Seller.

                  (b) INDEPENDENT  INVESTIGATION.  Buyer, in making the decision
to (i) pay the  Option  Price,  (ii)  exercise  the  Purchase  Option  and (iii)
purchase  the  Shares  from  Seller,  has not  relied  upon any oral or  written
representations  or assurances  from Seller or any of its  officers,  directors,
partners or employees or any other  representatives  or agents of Seller,  other
than the representations  and warranties set forth in this Agreement.  Buyer has
had access to all of the filings made by the Company  with the SEC,  pursuant to
the Exchange  Act and the  Securities  Act in each case to the extent  available
publicly via the SEC's Electronic Data Gathering, Analysis and Retrieval system.

                  (c)  AUTHORITY.  This  Agreement has been validly  authorized,
executed and  delivered by Buyer and assuming the due  authorization,  execution
and delivery thereof by Seller, is a valid and binding agreement  enforceable in
accordance  with its terms,  subject to the general  principles of equity and to
bankruptcy  or  other  laws  affecting  the  enforcement  of  creditors'  rights
generally.  The execution,  delivery and  performance of this Agreement by Buyer
does not and will not conflict with,  violate or cause a breach of, constitute a
default  under,  or result in a  violation  of (i) any  agreement,  contract  or
instrument to which Buyer is a party which would  prevent Buyer from  performing
its obligations  hereunder or (ii) any law, statute, rule or regulation to which
Buyer is subject.

                  (d) NO LEGAL ADVICE FROM SELLER.  Buyer  acknowledges  that is
has  had  the  opportunity  to  review  this  Agreement  and  the   transactions
contemplated by this Agreement with Buyer's own legal counsel and investment and
tax  advisors.  Buyer is relying  solely on such counsel and advisors and not on
any statements or  representations  of Seller or any of its  representatives  or
agents for legal, tax or investment advice with respect to this Agreement or the
transactions contemplated by this Agreement.

              9. COVENANTS.

                  (a) SELLER.  Seller hereby covenants and agrees (i) Seller has
owned the  Shares  for at least  sixty (60) days,  (ii)  Seller  will,  within 1
business day of execution of this Agreement,  provide  instructions to its prime
broker  substantially in the form of EXHIBIT A, which shall not allow the Shares
to be borrowed by, or lent to, any other person or entity whatsoever, (iii) that
except  pursuant to the terms of this Agreement,  Seller shall not,  directly or
indirectly,  (A) grant  any  proxies  or enter  into any  voting  trust or other
agreement  or  arrangement  with  respect  to the  voting of any of the  Shares,
regardless  of whether  such vote would  occur at the  Meeting or upon action by
written consent,(B) sell, assign, transfer, encumber or otherwise dispose of, or
enter into any  contract,  option or other  arrangement  or  understanding  with
respect to the direct or indirect  assignment,  transfer,  encumbrance  or other
disposition  of, any of the Shares during the term of this Agreement (C) seek or
solicit any such assignment,  transfer,  encumbrance or other disposition or any
such contract,  option or other arrangement or


                                      -6-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

understanding  with  respect to the  Shares,  (iv)  Seller  will use  reasonable
efforts to notify  Buyer,  and to provide all details  reasonably  requested  by
Buyer,  if Seller is  approached or solicited,  directly or  indirectly,  by any
reasonably well-known  alternative investment or institutional investor offering
to purchase all (or part) of the Shares, (v) Seller shall comply with all of its
filing obligations,  if any, under the Securities Act, and the Exchange Act with
respect to the Purchase Option,  exercise of the Purchase  Option,  or any other
transactions  contemplated by this Agreement;  PROVIDED,  HOWEVER,  Seller shall
file for  confidential  treatment of this  Agreement,  which at a minimum  shall
include the Option Price and Section 11, and  PROVIDED,  FURTHER,  Seller shall,
where legally permitted and practicably possible, allow counsel to Buyer one (1)
day to review any  submissions to the SEC (if such Filing  contains  information
with respect to the Buyer other than what is disclosed  in this  Agreement)  and
shall  incorporate  reasonable  comments that pertain to  information  regarding
Buyer,  (vi) Seller shall not share this Agreement or disclose any provisions of
this Agreement  with any other person;  PROVIDED,  HOWEVER,  Seller may disclose
this Agreement to (A) its group companies and its and their respective employees
and (B) its counsel and other advisors, each of whom Seller shall direct to keep
this  Agreement  confidential  and  (C)  where  required  by any  law,  rule  or
regulation  (including the rules of a  professional  body) binding on the Seller
and  (vii)  upon  being  contacted  by the  Company  or  any of its  affiliates,
including,  but not limited to the Company's  investment  bankers,  attorneys or
other representatives,  Seller may disclose to the Company that Seller no longer
controls the vote with respect to the Shares as a result of Seller entering into
an option agreement with respect to the Shares.

                  (b) BUYER.  Buyer hereby  covenants  and agrees that (i) Buyer
shall comply with all filing  obligations,  if any, under the Securities Act and
the Exchange Act, with respect to the Purchase Option,  exercise of the Purchase
Option,  any  subsequent  ownership  of the  Shares,  or any other  transactions
contemplated by this Agreement and (ii) Buyer shall be responsible for all costs
and expenses of the Escrow Agent.

              10.  TERMINATION.  Notwithstanding any provision in this Agreement
to the contrary and provided that the Buyer has not, at such time, exercised the
Purchase  Option,  this  Agreement  shall become null and void and of no further
force and effect  upon the  earlier to occur:  (i) the day on which the  Company
liquidates  its  trust  account  or (ii) by  unilateral  decision  of the  Buyer
communicated to the Seller in writing.  Upon any termination pursuant to Section
10, Seller shall retain the entirety of the aggregate Option Price.

              11. ***

              12.  13D  FILING.   Each  of  Buyer  and  Seller  acknowledge  and
understand  that by virtue of this  Purchase  Option,  or the  exercise  of such
Purchase  Option,  Buyer and/or Seller may be required to file a Schedule 13D or
Schedule  13D/A with the U.S.  Securities  and Exchange  Commission  (each,  the
"Filing")  and hereby  consents  to any such Filing  reasonably  required in the
opinion of Buyer,  Seller and/or their  respective  counsels.  Each of Buyer and
Seller  further  acknowledge  and  understand  that Buyer  and/or  Seller may be
required,  pursuant to the Exchange Act, to divulge certain information of Buyer
and/or  Seller,  including,  but not  limited  to, its name,  principals,  Share
position,  Option  Price,  Purchase  Price  and may be  required  to  file  this
Agreement  as an exhibit to any such  Filing.  Each of Buyer and Seller  further
covenant  and agree that it shall  allow the other  party or its counsel one (1)
business  day to review


                                      -7-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

the Filing (if such Filing  contains  information  with  respect to the Buyer or
Seller (as applicable) other than what is disclosed in this Agreement) and shall
incorporate  reasonable  comments  that pertain to  information  regarding  such
party.

              13. COUNTERPARTS; FACSIMILE. This Agreement may be executed in any
number of counterparts,  each of which when so executed shall be deemed to be an
original  and all of which  taken  together  shall  constitute  one and the same
instrument.  This  Agreement or any  counterpart  may be executed via  facsimile
transmission,  and any such  executed  facsimile  copy  shall be  treated  as an
original.

              14. GOVERNING LAW. This Agreement shall for all purposes be deemed
to be made under and shall be construed in accordance with the laws of the State
of Delaware.  Each of the parties  hereby agrees that any action,  proceeding or
claim against it arising out of or relating in any way to this Agreement  shall,
to the fullest extent applicable,  be brought and enforced first in the Delaware
Chancery Court, then to such other court in the State of Delaware as appropriate
and  irrevocably  submits  to such  jurisdiction,  which  jurisdiction  shall be
exclusive.  Each of the parties  hereby waives any  objection to such  exclusive
jurisdiction and that such courts represent an inconvenient forum.

              15. REMEDIES.  Each of the parties hereto  acknowledges and agrees
that, in the event of any breach of any covenant or agreement  contained in this
Agreement by the other party,  money damages may be  inadequate  with respect to
any such breach and the non-breaching  party may have no adequate remedy at law.
It is accordingly  agreed that each of the parties hereto shall be entitled,  in
addition to any other  remedy to which they may be entitled at law or in equity,
to seek  injunctive  relief  and/or to compel  specific  performance  to prevent
breaches by the other party  hereto of any  covenant or  agreement of such other
party  contained in this Agreement.  Accordingly,  Seller hereby agrees Buyer is
entitled to an injunction  prohibiting any conduct by the Seller in violation of
this  Agreement  and shall not seek the posting of any bond in  connection  with
such  request  for an  injunction.  Furthermore,  in any action to enforce  this
Agreement,  The parties  each waive their right to assert  set-off as a defense.
The  non-prevailing  party  agrees  to pay all  costs  and  expenses,  including
reasonable  attorneys'  and experts'  fees incurred by the  prevailing  party in
connection  with the  enforcement  of this  Agreement  in such  amount as may be
determined by the court of competent jurisdiction hearing such dispute.

              16.  SEVERABILITY.  If any term,  provision  or  covenant  of this
Agreement is held by a court of competent  jurisdiction or other authority to be
invalid,  void or  unenforceable,  the  remainder of the terms,  provisions  and
covenants of this  Agreement  shall remain in full force and effect and shall in
no way be affected, impaired or invalidated.

              17. BINDING EFFECT;  ASSIGNMENT AND TRANSFER. This Agreement shall
be  binding  upon and  inure to the  benefit  of the  parties  hereto  and their
respective  legal  representatives,   successors  and  permitted  assigns.  This
Agreement  shall not be assigned  or  transferred  by Seller.  Buyer may assign,
transfer or sell any of its rights under this Agreement at any time prior to the
exercise of the Purchase  Option  (collectively,  a "Transfer").  All rights and
obligations  of the Buyer shall  terminate  upon any such  Transfer and all such
rights and obligations shall be assumed by the transferee.


                                      -8-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

              18. HEADINGS.  The descriptive headings of the Sections hereof are
inserted for convenience only and do not constitute a part of this Agreement.

              19.  ENTIRE   AGREEMENT;   CHANGES  IN  WRITING.   This  Agreement
constitutes  the entire  agreement  among the parties  hereto and supersedes and
cancels any prior agreements,  representations  and warranties,  whether oral or
written,  among the  parties  hereto  relating to the  transaction  contemplated
hereby.  Neither  this  Agreement  not any  provision  hereof  may be changed or
amended  orally,  but only by an agreement in writing  signed by the other party
hereto.

              20. NOTICE.  All notices,  statements or other documents which are
required or  contemplated  by this  Agreement  shall be in writing and delivered
personally or sent by first class registered or certified mail, electronic mail,
overnight courier service or facsimile transmission to the address or fax number
most recently provided to such Person or such other address or fax number as may
be designated in writing by such Person.  Any notice or other  communication  so
transmitted  shall be  deemed  to have  been  given on the day of  delivery,  if
delivered  personally or if sent by electronic  mail or facsimile  transmission,
one (1) business day after delivery to an overnight  courier service or five (5)
days after mailing if sent by mail.

              Address for Notice:

Malibu Capital Partners, LLC [BUYER]       Arrowgrass Master Fund Ltd.  [SELLER]
15332 Antioch Street #528                  PO Box 242, 45 Market Street
Pacific Palisades, CA 90272                Gardenia Court, Camara Bay
                                           Grand Cayman KY1-1104
                                           Cayman Islands
With a copy to:
Sadis & Goldberg                           With a copy to:
551 Fifth Avenue, 21st Floor               Arrowgrass Capital Partners LLP
New York, New York 10176                   Level 39, Tower 42
Attn: Paul Fasciano, Esq.                  25 Old Broad Street
pfasciano@sglawyers.com                    London EC2N 1HQ
P: (212) 573-8025                          United Kingdom
F: (212) 573-8026                          Attn: Legal

                            [Signature Page Follows]








                                      -9-


CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"

              IN WITNESS  WHEREOF,  the undersigned have executed this Agreement
as of the date set forth on the first page of this Agreement.

                                             MALIBU CAPITAL PARTNERS, LLC
                                        By:  /s/ Kenneth J. Abdalla
                                             ----------------------------------
                                             Name:  Kenneth J. Abdalla
                                             Title: Managing Member



                                             ARROWGRASS MASTER FUND LTD.
                                        By:  /s/ Sean Flynn
                                             ----------------------------------
                                             Name:  Sean Flynn
                                             Title: Director


Option Price (per Share)                 ***
                                         ---
Purchase Price (per Share)*:
Number of Shares:                        1,856,220
Aggregate Option Price:                  ***
                                         ---
Aggregate Purchase Price*:

* Only to be  completed in  accordance  with Section 2 in the event the Purchase
Option is exercised












                   SIGNATURE PAGE TO OPTION PURCHASE AGREEMENT



CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"


                             [LETTERHEAD OF SELLER]


[INSERT BROKER NAME]
[INSERT BROKER ADDRESS]
[INSERT ATTN: DETAILS]

                  RE: Account No.  [INSERT ACCOUNT NUMBER]

Gentlemen:

              [NAME OF SELLER] ("we" or the "Company") are writing in regards to
the above  referenced  account  number (the  "Account")  held by [INSERT NAME OF
BROKER]  ("you").  With  respect to  [NUMBER]  of shares of the common  stock of
Overture  Acquisition  Corporation (the "Shares") held in our Account, we hereby
request  that  you do not,  in any  manner  whatsoever,  lend,  or  allow  to be
borrowed, for any period of time whatsoever, such Shares.

                                            Very truly yours

                                            [SELLER]


                                        By: /s/
                                            -----------------------------------
                                            Name:
                                            Title:


     Agree and accepted

     [BROKER]


By:/s/
   -----------------------------------
     Name:
     Title:






CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"


                              [LETTERHEAD OF BUYER]


[INSERT ESCROW AGENT NAME]
[INSERT ESCROW AGENT ADDRESS]
[INSERT ATTN: DETAILS]

                  RE: Account No.  [INSERT ACCOUNT NUMBER]

Gentlemen:

              [NAME OF BUYER] ("we" or the  "Company") are writing in regards to
the above  referenced  account  number  held by  [INSERT  NAME OF ESCROW  AGENT]
("you").  Pursuant  to the terms of an Option  Purchase  Agreement  between  the
Company and [INSERT  SELLER],  the Company has  exercised its option to purchase
[INSERT  NUMBER]  of shares  (the  "Shares")  of the  common  stock of  Overture
Acquisition  Corporation.  In consideration  for the electronic  transfer of the
Shares,  [using the  Depository  Trust  Company's  DWAC  (Deposit/Withdrawal  at
Custodian)  System],  to  the  Company's  specified  account,   you  are  hereby
irrevocably  instructed  to wire [AMOUNT] to [SELLER],  in  accordance  with the
wiring instructions provided below.

[INSERT WIRE INSTRUCTIONS]










                                       -1-



CONFIDENTIAL TREATMENT REQUESTED                                      EXHIBIT 1
WITH RESPECT TO CERTAIN PORTIONS HEREOF
DENOTED WITH "***"


The address for [SELLER] is [ADDRESS]. The contact person for [SELLER] is
[PERSON]. He can be reached at [NUMBER].

              Kindly acknowledge where indicated below:
                  (a) that you hold [Amount] on behalf of the
Company, which amount is available to be transferred to [Seller] pursuant to
this letter; and

                  (b) your receipt and understanding of these instructions

              and return a copy to Sadis & Goldberg,  attn: Paul Fasciano, Esq.,
facsimile  number  212-573-8026 and Arrowgrass  Capital Partners LLP,  facsimile
number +44 203 100 1363.

              A  facsimile  signed  and  electronically  delivered  copy of this
letter shall be deemed an original.


                                            Very truly yours

                                            [BUYER]


                                        By: /s/
                                            -----------------------------------
                                            Name:
                                            Title:


    Acknowledged and Agreed

    [ESCROW AGENT]


By: /s/
    ----------------------------------------
    Name:
    Title:


    [SELLER]


By:
    ----------------------------------------
    Name:
    Title:










                                      -2-